POR 102-16
Contract number: HT372-164431 001 CY
Contract award date: 2017-02-02
Date of delivery: June 7th, 2017
Prepared by:
Prepared for:
Health Canada
Ce rapport est disponible en français
Use of marijuana is common in Canada. In 2013, Health Canada’s Canadian Tobacco, Alcohol and Drugs Survey (CTADS) found that 11% of respondents 15 years of age and older reported using marijuana in the past year, with almost twice as many males reporting use than females. Canadians 15-24 years old were significantly more likely to use cannabis in past 12 months than those 25 years of age or older. Use is also common in students, with almost one in five students in grade 7-12 reporting past year use in the 2014-2015 Canadian Student Tobacco, Alcohol and Drugs Survey (CSTADS). International data for cannabis from 2013 showed the United States as the leader in lifetime prevalence rates at 43.7%Footnote 1, while Canada followed closely behind at 41.2%Footnote 2, and then the United Kingdom at 29.9%Footnote 3.
In 2015 Speech from the Throne, the Government of Canada committed to legalizing, regulating, and restricting access to marijuana. In 2016, the Government’s Task Force on Marijuana Legalization and Regulation issued a discussion paper entitled “Toward the legalization, regulation and restriction of access to marijuana” that initiated wider consultations and dialogue regarding its intention in this area.
The intention to legalize and regulate cannabis in Canada has also prompted a policy and scientific requirement to collect new comprehensive data on the subject of cannabis use and non-use, including indicators in the areas of health, public safety, and markets. New research on cannabis use is helping the government better evaluate the possible impacts associated with legalization, regulation, and restriction. In May and June 2016, Health Canada conducted the Baseline Survey on Awareness, Knowledge and Behavior Associated with Recreational Use of Marijuana (administered by Ekos Research Associate). This study examined the knowledge, perceived acceptability and health risks, pattern of recreational use, and information-seeking behaviors. This study found that 58% of respondents reported cannabis use in the past and that 22% reported use in the past 12 months. Among those who did not report use in the past 12 months, 85% felt they were unlikely to use cannabis once it becomes legal.
The Canadian Cannabis Survey examined in more depth patterns of use, such as the quantities used and medical use; the cannabis market, such as sources and pricing; and issues of public safety, such as impaired driving.
In conducting this research, Health Canada’s objective was to collect information on the following:
The total cost of this research was $249,820.40 including HST.
The approach used was a two-step recruitment process where respondents were first recruited by telephone (both land-line and mobile) using a short battery of screener questions approved by Health Canada. Respondents who completed the screener questions and qualified for the survey were then sent a link to the online survey, either by email or SMS depending on their preference. Respondents were recruited from lists of random telephone numbers (RDD) that Advanis verified were in service. The distribution of phone numbers was approximately 87 percent mobile phones and 13 percent landline numbers.
The rationale for using a higher volume of cell phone than landline numbers came from the requirement of oversampling youth aged 16 to 24 years old. From previous experience, we know that this group is very hard to reach by conventional landline for two majors reasons; first, they use their parents’ landline and we have difficulty reaching them; second, if they have left their parent’s house, they most likely use a cell phone rather than a landline.
In total, we called 181,435 phone numbers, and 18,702 people agreed to participate in the survey. Of these calls, 21 percent were conducted in French and 79 percent were conducted in English. The response rate calculation is presented in Appendix A.
During the computer assisted telephone interviews (CATI) recruit, Advanis requested permission to send the survey link to respondent’s mobile phones via a Short Message Service (SMS). The advantage of SMS survey invitations is that, unlike email invitations, it avoids issues with incorrect email addresses and spam filtering. If the recruited respondent did not have a smartphone or preferred email, survey links were sent via email. Of the respondents who completed the CATI screener, 70 percent were recruited via SMS, and 30 percent were recruited by email. Approximately half of those recruited to the online survey by SMS (49%), completed the online survey. Among those sent an email invitation, the completion rate of the online survey was 52 percent.
To increase the response rate, messages were left on the potential respondents’ voicemail, describing the study and informing the prospective respondent that they could call back the number that called them or a toll free number to participate. These calls were directed to the same group of telephone recruiters that made the initial calls. If the potential respondent called from the phone that was initially dialled, the calling record was automatically displayed to the recruiter.
Email reminders were sent 3 days and 6 days after the invitation. Advanis also conducted telephone reminders to those recruited by email to confirm emails had been received, and corrected email addresses if necessary. During these calls (only made once), voicemail messages were left reminding the respondents that the survey was still open and to call back if they had not received the invitation.
The average survey length for the questionnaire for users of cannabis in the past 12 months was 27 minutes, and it was 9 minutes on average for non-users. We need to keep in mind that, during an online survey, the time elapsed doesn’t necessarily align perfectly with survey duration since you can interrupt and restart your session. As for the duration of the recruitment interviews, the average length was 3 minutes.
The English pretest was conducted from March 9th to 12th, 2017. During this time, we recruited 123 people by phone, which then translated into 33 completed online surveys. The French pretest was conducted on March 15th with 50 phone interviews completed by the end of the day. The validation of the data was completed the morning of March 16th. This validation included users and non-users to ensure that all questions were tested. No changes were made to the survey following the pretest. The data collection period was from March 13th to May 24th.
Advanis utilizes technology to maximize quality control in survey programming. Having developed a proprietary survey engine tool, Advanis professionals are able to design and program a survey in a browser-based environment, eliminating the need to hand it off to a programmer who is less familiar with the survey subject matter. Below are the steps followed to ensure the quality of the surveys.
The CATI recruit script was programmed on Advanis’ proprietary CATI platform with no foreseen challenges. Advanis was able to leverage its experience for the survey programming and the reminder process to achieve high quality standards.
Advanis implemented the following to ensure the highest quality data collection:
To ensure high interview quality, our interviewers are trained to use various interviewing techniques. As well as maintaining a professional attitude, our interviewers must also be convincing, read word-for-word, take notes, probe deeper on semi-open and open questions, systematically confirm the information given and listen to the respondent.
All Advanis Web surveys are hosted internally by Advanis, and we employ a rigorous and stringent set of data collection control mechanisms to ensure the highest quality for the data collected, including:
For all of the data collected, Advanis develops rules to check the validity of the data. These rules include items such as:
Advanis staff has used the SPSS Statistics Software for 20 years and, as such, are very proficient users of the software. All data cleaning performed on a project is outlined in syntax files with intermediate data files saved throughout the process. This ensures that the original raw data file is never overwritten, and that if an error is discovered in our code, we can quickly and easily rerun the syntax to produce a new data file. Individuals developing code incorporate internal checks in their code (e.g., crosstabs) to ensure the syntax had the desired effect. In addition, all syntax is reviewed by another team member or technical specialist for accuracy.
The target audience of this project is Canadians who are 16 years and older. This study includes both users and non-users. A “user” is someone who has used cannabis in the last 12 months. The expected incidence of users in the general population is 11%, according to Statistics Canada data.
Key sub-population variables that required quotas were:
The sample consisted of a core sample of 2,000 Canadians aged 16 and older (users and non-users) with an original oversample plan of 1,600 cannabis users, for a total of 3,600 respondents. In the end, we gathered 9,215 responses in order to reach our target oversample and quotas. Table 1 presents the results for the entire data collection versus the quota for the base sample.
Region | Minimum Sample Size | Target Sample Size | Results |
---|---|---|---|
|
|||
WesternTable 1 note * | 400 | 500 | 2373 |
Ontario | 400 | 500 | 2163 |
Quebec | 400 | 500 | 2484 |
Maritimes | 400 | 500 | 2195 |
Age | Minimum Sample Size | Target Sample Size | Results |
16 to 19 years | 400 | 500 | 590 |
20 to 24 years | 400 | 500 | 1062 |
25 years and older | 400 | 1000 | 7563 |
Gender | Minimum Sample Size | Target Sample Size | Results |
Male | 800 | 1,000 | 4695 |
Female | 800 | 1,000 | 4486 |
Other | - | - | 34 |
Table 2 below presents the final results for users including both quota and oversample results.
Region | Minimum Sample Size | Target Sample Size | Results |
---|---|---|---|
|
|||
WesternTable 2 note * | 400 | 400 | 731 |
Ontario | 400 | 400 | 648 |
Quebec | 400 | 400 | 620 |
Maritimes | 400 | 400 | 650 |
Age | Minimum Sample Size | Target Sample Size | Results |
16 to 19 years | 200 | 500 | 252 |
20 to 24 years | 200 | 600 | 515 |
25 years and older | 200 | 500 | 1,882 |
Gender | Minimum Sample Size | Target Sample Size | Results |
Male | 600 | 800 | 1,539 |
Female | 600 | 800 | 1,097 |
Other | - | - | 13 |
Drivers | Minimum Sample Size | Target Sample Size | Results |
Users who have driven within 2 hrs of using cannabis | 600 | 1,000 | 979 |
Overall, 9,215 interviews were conducted during data collection, 2,451 in French and 6,764 in English. The weighting of the final file was based on three variables: region, age, and gender. For the 34 people who identified an “other gender identity”, a random gender was attributed for weighting purposes only. This group will be analyzed separately for analysis purposes. The population sizes are based on the latest Statistics Canada census results published, the 2016 Census. Since the value for the 16 to 19 age category wasn’t available (only 15 to 19 is provided), we reduced the 15 to 19 year category by 1/5 of the size to reflect the best estimate of the number of 16 to 19 year olds. See section 4.2 for guidelines on the limitations of analysis with the weights.
Group | Interviews | Weight interviews | Weight to population | Population |
---|---|---|---|---|
Atlantic – 16 to 19 – Female | 48 | 16 | 829.4 | 49 764 |
Ontario – 16 to 19 – Female | 92 | 101 | 4936.75 | 315 952 |
Quebec – 16 to 19 – Female | 84 | 54 | 2031.373494 | 168 604 |
West – 16 to 19 – Female | 97 | 81 | 4116.709677 | 255 236 |
Atlantic – 20 to 24 – Female | 103 | 21 | 727.3626374 | 66 190 |
Ontario – 20 to 24 – Female | 128 | 139 | 3410.703125 | 436 570 |
Quebec – 20 to 24 – Female | 172 | 79 | 1330.645161 | 247 500 |
West – 20 to 24 – Female | 142 | 111 | 3106.5625 | 347 935 |
Atlantic – 25 to 34 – Female | 216 | 42 | 546.659751 | 131 745 |
Ontario – 25 to 34 – Female | 249 | 281 | 3785.321888 | 881 980 |
Quebec – 25 to 34 – Female | 343 | 161 | 1438.778409 | 506 450 |
West – 25 to 34 – Female | 310 | 256 | 3005.449438 | 802 455 |
Atlantic – 35 to 44 – Female | 179 | 47 | 618.5564854 | 147 835 |
Ontario – 35 to 44 – Female | 211 | 285 | 4059.068182 | 892 995 |
Quebec – 35 to 44 – Female | 253 | 168 | 2257.991453 | 528 370 |
West – 35 to 44 – Female | 243 | 239 | 3414.659091 | 751 225 |
Atlantic – 45 to 54 – Female | 207 | 58 | 742.397541 | 181 145 |
Ontario – 45 to 54 – Female | 196 | 326 | 5302.823834 | 1 023 445 |
Quebec – 45 to 54 – Female | 182 | 182 | 3493.190184 | 569 390 |
West – 45 to 54 – Female | 211 | 251 | 4018.112245 | 787 550 |
Atlantic – 55+ – Female | 301 | 141 | 1660.657895 | 441 735 |
Ontario – 55+ – Female | 227 | 696 | 9832.522523 | 2 182 820 |
Quebec – 55+ – Female | 236 | 457 | 7318.494898 | 1 434 425 |
West – 55+ – Female | 282 | 539 | 7325.497835 | 1 692 190 |
Atlantic – 16 to 19 – Male | 60 | 17 | 1092.666667 | 52 448 |
Ontario – 16 to 19 – Male | 64 | 106 | 3623.695652 | 333 380 |
Quebec – 16 to 19 – Male | 83 | 56 | 2086.380952 | 175 256 |
West – 16 to 19 – Male | 62 | 86 | 278.474227 | 270 288 |
Atlantic – 20 to 24 – Male | 91 | 22 | 657.6213592 | 67 735 |
Ontario – 20 to 24 – Male | 128 | 146 | 3576.679688 | 457 815 |
Quebec – 20 to 24 – Male | 186 | 81 | 1468.604651 | 252 600 |
West – 20 to 24 – Male | 112 | 117 | 2579.859155 | 366 340 |
Atlantic – 25 to 34 – Male | 241 | 41 | 590.3935185 | 127 525 |
Ontario – 25 to 34 – Male | 233 | 273 | 3442.349398 | 857 145 |
Quebec – 25 to 34 – Male | 352 | 161 | 1470.758017 | 504 470 |
West – 25 to 34 – Male | 267 | 256 | 2592.370968 | 803 635 |
Atlantic – 35 to 44 – Male | 239 | 43 | 761.6480447 | 136 335 |
Ontario – 35 to 44 – Male | 220 | 262 | 3892.725118 | 821 365 |
Quebec – 35 to 44 – Male | 234 | 169 | 2089.703557 | 528 695 |
West – 35 to 44 – Male | 220 | 235 | 3031.604938 | 736 680 |
Atlantic – 45 to 54 – Male | 244 | 54 | 825.4830918 | 170 875 |
Ontario – 45 to 54 – Male | 193 | 309 | 4950.382653 | 970 275 |
Quebec – 45 to 54 – Male | 163 | 182 | 3129.010989 | 569 480 |
West – 45 to 54 – Male | 196 | 244 | 3629.763033 | 765 880 |
Atlantic – 55+ – Male | 266 | 125 | 1305.664452 | 393 005 |
Ontario – 55+ – Male | 222 | 607 | 8389.581498 | 1 904 435 |
Quebec – 55+ – Male | 196 | 402 | 5338.622881 | 1 259 915 |
West – 55+ – Male | 231 | 490 | 5453.421986 | 1 537 865 |
Introducing weighting generates a design effect that can be attributed to weight variation. This effect increases the sampling error in comparison to the random sampling without weighting.
The following table presents the design effect (the effect of the sampling plan on the statistical power of the sample) for each region separately as well as for the entire sample. Also, this table shows the size of an “efficient” sample, which corresponds to the size of the random sample which would have the same precision degree. For the total sample, the variation of the sampling fractions comes from the fact that the same number of interviews is done in each region regardless of region size.
Province | Mean of weights | N | Population | Standard deviation | Design effect | Usable sample size | Margin of error |
---|---|---|---|---|---|---|---|
Canada | 3136.9450 | 9215 | 28 906 948 | 2187.1192 | 1.48610612 | 6201 | 1.2 % |
Atlantic | 895.8255 | 2195 | 1 966 337 | 366.4411 | 1.16732526 | 1880 | 2.3 % |
Québec | 2715.4408 | 2484 | 6 745 155 | 1778.7189 | 1.42907572 | 1738 | 2.4 % |
Ontario | 5121.6722 | 2163 | 11 078 177 | 2143.8969 | 1.17522023 | 1841 | 2.3 % |
West | 3842.0898 | 2373 | 9 117 279 | 1425.6758 | 1.13769132 | 2086 | 2.2 % |
After the data collection was completed, data cleaning was performed to ensure a high quality of results. There were three minor changes made to the metric questions as there were extra answers after three respondents changed their minds and went back to change a previous answer.
The next step was to perform any necessary data coding. A detailed scale was used to describe quantities across the survey. Once data collection was completed, these scales were transformed into metric questions for ease of analysis. The metric question type simplifies the analysis by easily providing mean, median, etc. measures. For this recoding of scales into a metric value, the midpoint of the scale was used to create the metric value.
A review of open-ended responses was also performed as part of the data cleaning. Any “other” responses were recoded into existing categories when appropriate. A coding guide was created for answers that had sufficient numbers of mentions to be added in as a new response level. Specific verbatim themes that did not have a sufficient number of mentions were left in the “other” category.
When doing an analysis, it is important to align the analysis plan with the weighting scheme. The weights adjust the data to better reflect the population based on parameters that have been chosen to maximize the level of detail without creating distortions due to extreme weights (an extreme weight will occur when a population group is represented by a proportionally smaller subset of respondents compared to other population groups, thus introducing an important risk of bias due to their specific profile).
For this study, the basic sociodemographical information that should be used in analysis of results is:
Using age groupings other than the ones described above for these sociodemographic categories could potentially produce distorted data. As these results would be inaccurate based on how the weights were calculated, we strongly advise not to report any results that are not aligned with these specified categories.
In the provided data file, the variable to use in your statistical analysis program to weight the data is simply called “weights”. In this case, it was decided to project to the total population, around 28 million Canadian residents.
Any results with an unweighted base of 30 respondents or fewer should not be reported on, due to statistical robustness. Results with more than 30 but fewer than 50 respondents should be interpreted with caution, and considered as directional guidelines. Results based on 50 or more respondents have not been noted in any way. The reason for suppressing results with small base sizes is due to the increased coefficient of variation and hence larger confidence intervals around results with smaller bases to the point of rendering reported values ineffective in that they are too broad to be meaningful statistics in application.
CV range | Estimate Stability |
---|---|
*CV= (standard error / coefficient) * 100 where the coefficient is either the regression coefficient or the proportion estimate. | |
0 – 16.5 | Acceptable, the estimate stable |
16.6 – 33.3 | Marginal, the estimate has moderate sampling variability and should be interpreted with caution |
>33.3 | Unacceptable, the estimate is unstable and should be suppressed |
TOTAL | % | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GENERATED | 181435 | 100.0% | |||||||||||||||||||
|
|||||||||||||||||||||
USED | 181435 | 100.0% | |||||||||||||||||||
Not in service | 2633 | 1.5% | |||||||||||||||||||
Not residential | 1044 | 0.6% | |||||||||||||||||||
Line problem | 867 | 0.5% | |||||||||||||||||||
Fax | 84 | 0.0% | |||||||||||||||||||
Wrong number | 502 | 0.3% | |||||||||||||||||||
A | NOT VALID | 5130 | 2.8% | ||||||||||||||||||
VALID | 176305 | 97.2% | |||||||||||||||||||
Not eligible | 3603 | 2.0% | |||||||||||||||||||
Language barrier | 720 | 0.4% | |||||||||||||||||||
Age – Illness | 121 | 0.1% | |||||||||||||||||||
Other | 55 | 0.0% | |||||||||||||||||||
B | NOT SAMPLE | 4499 | 2.5% | ||||||||||||||||||
SAMPLE | 171806 | 94.7% | |||||||||||||||||||
C | Household refusal | 42325 | 24.6% | ||||||||||||||||||
Multiple household refusal | 1 | 0.0% | |||||||||||||||||||
D | Respondent refusal | 20823 | 12.1% | ||||||||||||||||||
Multiple respondent refusal | 53 | 0.0% | |||||||||||||||||||
D | FINAL refusal | 2137 | 1.2% | ||||||||||||||||||
D | Prolonged absence | 47 | 0.0% | ||||||||||||||||||
D | Incomplete | 2 | 0.0% | ||||||||||||||||||
C | No answer | 78248 | 45.5% | ||||||||||||||||||
D | Appointments | 9468 | 5.5% | ||||||||||||||||||
Completed interviews | 18702 | 10.9% | |||||||||||||||||||
% REFUSAL | 38.0% | ||||||||||||||||||||
% COMPLETED | 10.9% | ||||||||||||||||||||
ELIGIBILITY RATE | 91.9% | ||||||||||||||||||||
MRIA RESPONSE RATE | 11.5% |
Political neutrality certification
I hereby certify as Senior Officer of Advanis that the deliverables fully comply with the Government of Canada political neutrality requirements outlined in the Communications Policy of the Government of Canada and Procedures for Planning and Contracting Public Opinion Research.
Specifically, the deliverables do not include information on electoral voting intentions, political party preferences, standings with the electorate, or ratings of the performance of a political party or its leaders.
Signed:
Nicolas Toutant, Vice-President, Research and Evaluation
Introduction
Health Canada is conducting this research survey on knowledge about and use of cannabis. Advanis has been hired to administer the survey. Si vous préférez répondre au sondage en français, veuillez cliquer sur FRANÇAIS.
The survey takes between 5 and 20 minutes to complete and is voluntary and completely confidential. Your answers will remain anonymous. If you wish to verify the authenticity of this survey please email: ODSS.BSSD@hc-sc.gc.ca
The survey automatically moves to the next question when possible; however in some cases you need to press the right arrow button at the bottom of the screen to move to the next question. This button will not appear until you have answered the question.
To change previous answers you can press the left arrow button at the bottom of the screen. Some questions provide further information if you press the following symbol: (?)
If you need to stop the survey at any point you can return at a later time and the survey will continue where you left off.
For help you can contact 866-820-5163.
MainInto
In this survey when we use the term cannabis, this includes marijuana (e.g., weed, pot), hashish, hash oil or any other products made from the cannabis plant but not synthetic cannabinoids. When we ask about use, this includes using cannabis in its dry form or when mixed or processed into another product such as an edible, a concentrate, including hashish, a liquid, or other product for non-medical purposes. By non-medical purposes we mean recreational (e.g., for enjoyment, pleasure, amusement), socially, for spiritual, lifestyle and other similar non-medical uses.
Completely acceptable |
Somewhat acceptable |
Somewhat unacceptable |
Completely unacceptable |
No opinion | ||
---|---|---|---|---|---|---|
a. | Alcohol | 1 | 2 | 3 | 4 | 5 |
b. | Tobacco (cigarette/cigar/snuff) | 1 | 2 | 3 | 4 | 5 |
c. | Tobacco (vaping) | 1 | 2 | 3 | 4 | 5 |
d. | Smoking cannabis for non-medical purposes | 1 | 2 | 3 | 4 | 5 |
e. | Vaping cannabis for non-medical purposes | 1 | 2 | 3 | 4 | 5 |
f. | Eating cannabis for non-medical purposes | 1 | 2 | 3 | 4 | 5 |
Positive effect | No effect | Negative effect | Don’t know | ||
---|---|---|---|---|---|
a. | Motivation or ambition | 1 | 2 | 3 | 4 |
b. | Mood | 1 | 2 | 3 | 4 |
c. | Creativity | 1 | 2 | 3 | 4 |
d. | Inhibitions or shyness | 1 | 2 | 3 | 4 |
e. | Anxiety | 1 | 2 | 3 | 4 |
f. | Sleep | 1 | 2 | 3 | 4 |
g. | Memory | 1 | 2 | 3 | 4 |
h. | Ability to concentrate | 1 | 2 | 3 | 4 |
i. | Attention | 1 | 2 | 3 | 4 |
j. | Thinking, decision-making | 1 | 2 | 3 | 4 |
During the past 12 months, have you noticed anyone using cannabis in publicly accessible places (e.g., street, park, alley, mall, etc.)?
(Please check all that apply and press the right arrow at bottom when you are done)
How many of your immediate family members (e.g., parents, siblings, and children) do you think have tried cannabis for non-medical purposes?
In the past 12 months, how have people, including yourself, used cannabis for non-medical purposes inside your home?
(Please check all that apply.)
As far as you know, when is it safe for someone to drive a vehicle after using cannabis for non-medical purposes?
Have you ever been a passenger in a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) driven by someone who had used cannabis for non-medical purposes within 2 hours before driving?
When did this last happen?
During your lifetime have you ever used cannabis for non-medical purposes?
How many times?
Page Show If Have_NOT_used_in_lifetime_nonmedical
Page Show If Have_used_in_lifetime_nonmedical
Section Show If Is_Nonmedical_User
Page Show If Is_Nonmedical_User_30_Days
In the past 12 months, did you use the following method to consume cannabis for non-medical purposes?
(Please check all that apply.)In the past 12 months, have you used the following cannabis products for non-medical purposes?
(Please check all that apply.)Page Show If Used_12_months_Some_Form
Less than 1 day per month |
1 day per month |
2 or 3 days a month |
1 or 2 days per week |
3 or 4 days per week |
5 or 6 days per week |
Daily | ||
---|---|---|---|---|---|---|---|---|
a. | Dried flower/leaf (smoked or vaporized) [Show If Used_12_months_Dried_Flower] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
b. | Hashish/kief [Show If Used_12_months_Hashish] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
c. | Liquid concentrate (e.g., hash oil, butane honey oil, etc.) [Show If Used_12_months_Liquid_Concentrate] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
d. | Cannabis oil cartridges or disposable vape pens [Show If Used_12_months_Cartridge] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
e. | Solid concentrate (e.g., shatter, budder, etc.) [Show If Used_12_months_Solid] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
f. | Edibles (e.g., prepared food products) [Show If Used_12_months_Edibles] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
g. | Liquid (e.g., cola/tea) [Show If Used_12_months_Liquid] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
h. | Other: <<Q24a.specify(8)>> [Show If Used_12_months_Other] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
For these methods of consuming cannabis, please select the methods where you know the percentage or milligrams of THC and CBD for the amount you typically consume.
(Please check all that apply.)Page Show If Used_12_months_Dried_Flower
On the days that you used: Dried flower/leaf (smoked or vaporized)
How much did you typically use in a day?
(Please select the amount closest to what you typically use.)
What percentage of THC is in this product? tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.
(Dried flower/leaf (smoked or vaporized))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Dried flower/leaf (smoked or vaporized))
Page Show If Used_12_months_Hashish
On the days that you used: Hashish/kief
How much did you typically use in a day?
(Please select the amount closest to what you typically use.)
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Hashish/kief)
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Hashish/kief)
Page Show If Used_12_months_Liquid_Concentrate
On the days that you used: Liquid concentrate (e.g., hash oil, butane honey oil, etc.)
How much did you typically use in a day?
(Please select the amount closest to what you typically use.)
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Liquid concentrate (e.g., hash oil, butane honey oil, etc.))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Liquid concentrate (e.g., hash oil, butane honey oil, etc.))
page Show If Used_12_months_Cartridge
On the days that you used: Cannabis oil cartridges or disposable vape pens
How much did you typically use in a day?
(Please select the amount closest to what you typically use.)
How many milligrams per cartridge/pen of THC are in this product? Tetrahydrocannabinol is the substance in cannabis responsible for the “high” and other effects.
(Cannabis oil cartridges or disposable vape pens)
How many milligrams per cartridge/pen of CBD are in this product? Cannabidiol is a substance in cannabis that does not produce the “high”, but has other effects.
Cannabis oil cartridges or disposable vape pens
Page Show If Used_12_months_Solid
On the days that you used: Solid concentrate (e.g., shatter, budder, etc.)
How much did you typically use in a day?
(Please select the amount closest to what you typically use.)
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Solid concentrate (e.g., shatter, budder, etc.))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Solid concentrate (e.g., shatter, budder, etc.))
Page Show If Used_12_months_Edibles
On the days that you used: Edibles (e.g., prepared food products)
How much did you typically use in a day?
(Please select the amount closest to what you typically use.)
How many milligrams per serving of THC are in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Edibles (e.g., prepared food products))
How many milligrams per serving of CBD are in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Edibles (e.g., prepared food products))
Page Show If Used_12_months_Liquid
On the days that you used: Liquid (e.g., cola/tea)
How much did you typically use in a day?
(Please select the amount closest to what you typically use.)
How many milligrams per ml of THC are in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Liquid (e.g., cola/tea))
How many milligrams per ml of CBD are in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Liquid (e.g., cola/tea))
Page Show If Used_12_months_Other
On the days that you used: Other: <<Q24a.specify(8)>>
How much did you typically use in a day?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Other: <<Q24a.specify(8)>>)
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Other: <<Q24a.specify(8)>>)
In the past 12 months, how many different people/sources have you obtained cannabis for non-medical purposes from?
In the past 12 months, from what venue(s) (locations) did you obtain cannabis for non-medical purposes?
Where did you grow your cannabis?
How far would you be willing to travel to purchase cannabis for non-medical purposes?
Which factors would influence your willingness to travel to purchase cannabis for non-medical purposes?
In the past 12 months, could you get other types of illicit drugs from the person or place that you got cannabis for non-medical purposes from most often?
How much do you typically spend on cannabis for non-medical purposes each month?
Page Show If Is_Nonmedical_User_30_Days
How much did you spend on cannabis for non-medical purposes in the past 30 days?
In the past 30 days, which forms of cannabis have you bought or received for non-medical purposes?
(Please check all that apply.)
1 day per month |
2 or 3 days per month |
1 or 2 day(s) per week |
3 or 4 days per week |
5 to 6 days per week |
Daily | ||
---|---|---|---|---|---|---|---|
a. | Dried flower/leaf (smoked or vaporized) [Show If Used_30_days_Dried_Flower] |
2 | 3 | 4 | 5 | 6 | 7 |
b. | Hashish/kief [Show If Used_30_days_Hashish] |
2 | 3 | 4 | 5 | 6 | 7 |
c. | Liquid concentrate (e.g., hash oil, butane honey oil, etc.) [Show If Used_30_days_Liquid_Concentrate] |
2 | 3 | 4 | 5 | 6 | 7 |
d. | Cannabis oil cartridges or disposable vape pens [Show If Used_30_days_Cartridge] |
2 | 3 | 4 | 5 | 6 | 7 |
e. | Solid concentrate (e.g., shatter, budder, etc.) [Show If Used_30_days_Solid] |
2 | 3 | 4 | 5 | 6 | 7 |
f. | Edibles (e.g., prepared food products) [Show If Used_30_days_Edibles] |
2 | 3 | 4 | 5 | 6 | 7 |
g. | Liquid (e.g., cola/tea) [Show If Used_30_days_Liquid] |
2 | 3 | 4 | 5 | 6 | 7 |
h. | Other: <<Q37a.specify(8)>> [Show If Used_30_days_Other] |
2 | 3 | 4 | 5 | 6 | 7 |
Page Show If Used_30_days_Dried_Flower
Typically, how much cannabis in the form: Dried flower/leaf (smoked or vaporized)
Did you buy or receive each time for non-medical purposes?
(Please select the amount closest to what you typically use.)
How much did you pay for this amount?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Dried flower/leaf (smoked or vaporized))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Dried flower/leaf (smoked or vaporized))
Page Show If Used_30_days_Hashish
Typically, how much cannabis in the form Hashish/kief did you buy or receive each time for non-medical purposes?
(Please select the amount closest to what you typically use.)
How much did you pay for this amount?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Hashish/kief)
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Hashish/kief)
Page Show If Used_30_days_Liquid_Concentrate
Typically, how much cannabis in the form Liquid concentrate (e.g., hash oil, butane honey oil, etc.) did you buy or receive each time for non-medical purposes?
(Please select the amount closest to what you typically use.)
How much did you pay for this amount?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Liquid concentrate (e.g., hash oil, butane honey oil, etc.))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Liquid concentrate (e.g., hash oil, butane honey oil, etc.))
Page Show If Used_30_days_Cartridge
Typically, how much cannabis in the form Cannabis oil cartridges or disposable vape pens did you buy or receive each time for non-medical purposes?
(Please select the amount closest to what you typically use.)
How much did you pay for this amount?
How many milligrams per cartridge/pen of THC are in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Cannabis oil cartridges or disposable vape pens)
How many milligrams per cartridge/pen of CBD are in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Cannabis oil cartridges or disposable vape pens)
Page Show If Used_30_days_Solid
Typically, how much cannabis in the form Solid concentrate (e.g., shatter, budder, etc.) did you buy or receive each time for non-medical purposes?
(Please select the amount closest to what you typically use.)
How much did you pay for this amount?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Solid concentrate (e.g., shatter, budder, etc.))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Solid concentrate (e.g., shatter, budder, etc.))
Page Show If Used_30_days_Edibles
Typically, how much cannabis in the form Edibles (e.g., prepared food products) did you buy or receive each time for non-medical purposes?
(Please select the amount closest to what you typically use.)
How much did you pay for this amount?
How many milligrams per serving of THC are in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Edibles (e.g., prepared food products))
How many milligrams per serving of CBD are in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Edibles (e.g., prepared food products))
Page Show If Used_30_days_Liquid
Typically, how much cannabis in the form Liquid (e.g., cola/tea) did you buy or receive each time for non-medical purposes?
(Please select the amount closest to what you typically use.)
How much did you pay for this amount?
How many milligrams per ml of THC are in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Liquid (e.g., cola/tea))
How many milligrams per ml of CBD are in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Liquid (e.g., cola/tea))
Page Show If Used_30_days_Other
Typically, how much cannabis in the form Other: <<Q37a.specify(8)>> did you buy or receive each time for non-medical purposes?
(Please select the amount closest to what you typically use.)
How much did you pay for this amount?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Other: <<Q37a.specify(8)>> )
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Other: <<Q37a.specify(8)>> )
Page Show If Bought_nonmedical_cannabis
In the past 12 months, have you shared or gifted any of the cannabis you obtained for non-medical purposes with others by passing a joint/bong/pipe around in a group?
In the past 12 months, have you shared or gifted any of the cannabis you obtained for non-medical purposes with others by passing a joint/bong/pipe around in a group?
In the past 12 months, have you shared or gifted any of the cannabis you obtained for non-medical purposes with others, not including sharing while consuming (e.g., passing a joint/bong/pipe around in a group)? For example, giving some cannabis to a friend to take away with them.
In the past 12 months, where have you used cannabis for non-medical purposes?
In the past 12 months, how often did you use cannabis for non-medical purposes to get “stoned” or “high” before going to, or while at, school/college/university?
In the past 12 months, how often did you use cannabis for non-medical purposes to ‘get high’ before going to, or while at, work?
Rarely | Sometimes | Often | Always | ||
---|---|---|---|---|---|
a. | Spouse/partner [Show If Q49a_1_Spouse/partner] |
1 | 2 | 3 | 4 |
b. | Family member or relative [Show If Q49a_2_Family_member] |
1 | 2 | 3 | 4 |
c. | Friend(s) [Show If Q49a_3_Friend(s)] |
1 | 2 | 3 | 4 |
d. | Co-worker(s) [Show If Q49a_4_Co-worker(s)] |
1 | 2 | 3 | 4 |
e. | Stranger(s) [Show If Q49a_5_Stranger(s)] |
1 | 2 | 3 | 4 |
f. | Dealer [Show If Q49a_6_Dealer] |
1 | 2 | 3 | 4 |
g. | While alone [Show If Q49a_7_While_alone] |
1 | 2 | 3 | 4 |
h. | Other: <<Q49a.specify(8)>> [Show If Q49a_8_Other] |
1 | 2 | 3 | 4 |
Never | Rarely | Sometimes | Often | Always | ||
---|---|---|---|---|---|---|
a. | Alcohol | 1 | 2 | 3 | 4 | 5 |
b. | Tobacco or e-cigarette | 1 | 2 | 3 | 4 | 5 |
c. | Prescription pain relievers (e.g., Oxy, Dilaudid®, morphine, Demerol, Tylenol #3®) | 1 | 2 | 3 | 4 | 5 |
d. | Prescription stimulants (e.g., Ritalin®, Concerta®, Adderall®, Dexedrine) | 1 | 2 | 3 | 4 | 5 |
e. | Prescription sedatives/tranquilizers (e.g., diazepam, lorazepam, Valium®, Ativan®, alprazolam, Xanax®, clonazepam, Rivotril®) | 1 | 2 | 3 | 4 | 5 |
f. | Illicit opioids (e.g., heroin, non-pharmaceutical fentanyl) | 1 | 2 | 3 | 4 | 5 |
g. | Illicit stimulants (e.g., cocaine, crack, methamphetamine, ecstasy/MDMA) | 1 | 2 | 3 | 4 | 5 |
h. | Illicit hallucinogens/dissociatives (e.g., LSD, magic mushrooms, ketamine, PCP) | 1 | 2 | 3 | 4 | 5 |
Page Show If Used_Combination_Some_Drugs
Yes | No | ||
---|---|---|---|
a. | Alcohol [Show If Used_Combination_Alcohol] |
1 | 2 |
b. | Tobacco or e-cigarette [Show If Used_Combination_Tobacco] |
1 | 2 |
c. | Prescription pain relievers (e.g., Oxy, Dilaudid®, morphine, Demerol, Tylenol #3®) [Show If Used_Combination_Pain_Relievers] |
1 | 2 |
d. | Prescription stimulants (e.g., Ritalin®, Concerta®, Adderall®, Dexedrine) [Show If Used_Combination_Stimulants] |
1 | 2 |
e. | Prescription sedatives/tranquilizers (e.g., diazepam, lorazepam, Valium®, Ativan®, alprazolam, Xanax®, clonazepam, Rivotril®) [Show If Used_Combination_Sedatives] |
1 | 2 |
f. | Illicit drugs (e.g., Cocaine, crack, heroin, ecstasy/MDMA, methamphetamine, LSD, magic mushrooms, ketamine, PCP) [Show If Used_Combination_Illicit_Drugs] |
1 | 2 |
Page Show If Driven_within_2_hours_nonmedical
In the past 12 months, how many times have you driven a motor vehicle (e.g. car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of using cannabis for non-medical purposes?
In the past 30 days, how many times have you driven a motor vehicle (e.g. car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of using cannabis for non-medical purposes?
Have you driven a motor vehicle (e.g. car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of using cannabis for non-medical purposes in combination with alcohol?
When did this last happen?
Have you driven a motor vehicle (e.g. car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of using cannabis for non-medical purposes in combination with another drug other than alcohol or tobacco?
When did this last happen?
In the past 12 months, how many times have you been in a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) accident or collision with you as a driver after using cannabis for non-medical purposes within 2 hours before driving?
In the past 12 months, have you, as the driver, ever had an interaction with law enforcement involving driving under the influence of cannabis?
Positive effect | No effect | Negative effect | ||
---|---|---|---|---|
a. | Friendships or social life | 1 | 2 | 3 |
b. | Physical health | 1 | 2 | 3 |
c. | Physical mobility | 1 | 2 | 3 |
d. | Mental health | 1 | 2 | 3 |
e. | Home life or marriage | 1 | 2 | 3 |
f. | Work or studies | 1 | 2 | 3 |
g. | Quality of life | 1 | 2 | 3 |
Page Show If Was_Victimized
How were you victimized?
How was cannabis related to this victimization?
Page Show If Did_use_past_3_months_nonmedical
Page Show If Is_Adult
What is the highest certificate, diploma or degree that you have completed?
Which of the following categories best describes your total household income that is the total income of all persons in your household before taxes?
What language(s) do you speak most often at home?
(Please check all that apply.)
Section Show If Is_Medical_User
You indicated that you have used cannabis for medical purposes. Would you be willing to complete a series of questions asking about your use of cannabis for medical purposes?
(Please remember that you can stop the survey and return at a later time.)
MTerminate Show If Unwilling_to_Complete_Medical_Use_Section
You have now completed the survey. Thank you very much for participating in this survey.
MInto
In this series of questions when we use the term cannabis, this includes marijuana, hashish, hash oil or any other products made from the cannabis plant but not synthetic cannabinoids.
When we ask about use, this includes using cannabis in its dry form or when mixed or processed into another product such as an edible, concentrate, liquid, or other product for medical purposes.
Do you have a medical document from a healthcare professional to use cannabis for medical purposes?
Did you ever have a medical document from a healthcare professional to use cannabis for medical purposes in the past?
Are you currently accessing cannabis for medical purposes through the Health Canada program (e.g., Access to Cannabis for Medical Purposes (ACMPR))?
Have you accessed cannabis for medical purposes through the Health Canada program (e.g., ACMPR/MMPR/MMAR) in the past?
Do you access or have accessed cannabis for medical purposes through another source other than the Health Canada program (e.g., ACMPR/MMPR/MMAR)?
Why did you stop accessing cannabis through the Health Canada program (e.g., ACMPR/MMPR/MMAR)?
(Please check all that apply.)
For which of the following diseases do you use cannabis for medical purposes?
(Please check all that apply.)
How has your use of cannabis for medical purposes allowed you to change your use of other medications?
Which medication(s) have you been able to reduce your use of since starting to use cannabis for medical purposes?
(Please check all that apply.)
Which medication(s) have you increased your use of since starting to use cannabis for medical purposes?
(Please check all that apply.)
In the past 12 months, where did you get the cannabis you used for medical purposes from?
(Please check all that apply.)
Is your grow registered with Health Canada?
Is the grow for you registered with Health Canada?
In the past 12 months, which of the following cannabis products did you use for medical purposes?
(Please check all that apply.)
Less than 1 day per month |
1 day per month |
2 or 3 days a month |
1 or 2 days per week |
3 or 4 days per week |
5 or 6 days per week |
Daily | ||
---|---|---|---|---|---|---|---|---|
a. | Dried flower/leaf (smoked or vaporized) [Show If M12a_1_Dried_flower] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
b. | Hashish [Show If M12a_2_Hashish] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
c. | Cannabis Oil from a Health Canada Licensed Producer [Show If M12a_3_Cannabis_Oil_from_HC] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
d. | Liquid concentrate (e.g., hash oil, butane honey oil, etc.) [Show If M12a_4_Liquid_concentrate] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
e. | Cannabis oil cartridges or disposable vape pens [Show If M12a_5_Cannabis_oil_cartridges] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
f. | Solid concentrate (e.g., shatter, budder, etc.) [Show If M12a_6_Solid_concentrate] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
g. | Edibles (e.g., prepared food products) [Show If M12a_7_Edibles] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
h. | Liquid (e.g., cola/tea) [Show If M12a_8_Liquid] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
i. | Tinctures (e.g., concentrated amounts ingested orally or taken under the tongue) [Show If M12a_9_Tinctures] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
j. | Topical Ointments (e.g., lotions, salves, balms applied directly to the skin) [Show If M12a_10_Topical_Ointment] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
k. | Fresh flower/leaf (e.g., for juicing) [Show If M12a_11_Fresh_flower] |
1 | 2 | 3 | 4 | 5 | 6 | 7 |
Page Show If Use_different_strains_specific_times_medical_purposes
As soon as you wake up |
Morning | Afternoon | Evening | Before bed | ||
---|---|---|---|---|---|---|
a. | High THC, low CBD [Show If M15a_1_High_THC_low_CBD] |
1 | 2 | 3 | 4 | 5 |
b. | High THC, mid CBD [Show If M15a_2_High_THC_mid_CBD] |
1 | 2 | 3 | 4 | 5 |
c. | High THC, high CBD [Show If M15a_3_High_THC_high_CBD] |
1 | 2 | 3 | 4 | 5 |
d. | Mid THC, low CBD [Show If M15a_4_Mid_THC_low_CBD] |
1 | 2 | 3 | 4 | 5 |
e. | Mid THC, mid CBD [Show If M15a_5_Mid_THC_mid_CBD] |
1 | 2 | 3 | 4 | 5 |
f. | Mid THC, high CBD [Show If M15a_6_Mid_THC_high_CBD] |
1 | 2 | 3 | 4 | 5 |
g. | Low THC, low CBD [Show If M15a_7_Low_THC_low_CBD] |
1 | 2 | 3 | 4 | 5 |
h. | Low THC, mid CBD [Show If M15a_8_Low_THC_mid_CBD] |
1 | 2 | 3 | 4 | 5 |
i. | Low THC, high CBD [Show If M15a_9_Low_THC_high_CBD] |
1 | 2 | 3 | 4 | 5 |
Page Show If Used_12_months_medical_Dried_Flower
On the days that you used: Dried flower/leaf (smoked or vaporized) for medical purposes how much did you typically use in a day?
(Please select the amount closest to what you typically use.)
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Dried flower/leaf (smoked or vaporized))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Dried flower/leaf (smoked or vaporized))
Page Show If Used_12_months_medical_Hashish
On the days that you used: Hashish/kief for medical purposes how much did you typically use in a day?
(Please select the amount closest to what you typically use.)
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Hashish/kief)
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Hashish/kief)
Page Show If Used_12_months_medical_Cannabis_Oil_HC
On the days that you used: Cannabis Oil from a Health Canada Licensed Producer for medical purposes how much did you typically use in a day?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Cannabis Oil from a Health Canada Licensed Producer)
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Cannabis Oil from a Health Canada Licensed Producer)
Page Show If Used_12_months_medical_Liquid_Concentrate
On the days that you used: Liquid concentrate (e.g., hash oil, butane honey oil, etc.) for medical purposes how much did you typically use in a day?
(Please select the amount closest to what you typically use.)
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Liquid concentrate (e.g., hash oil, butane honey oil, etc.))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Liquid concentrate (e.g., hash oil, butane honey oil, etc.))
Page Show If Used_12_months_medical_Cartridge
On the days that you used: Cannabis oil cartridges or disposable vape pens for medical purposes how much did you typically use in a day?
(Please select the amount closest to what you typically use.)
How many milligrams per cartridge/pen of THC are in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Cannabis oil cartridges or disposable vape pens)
How many milligrams per cartridge/pen of CBD are in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Cannabis oil cartridges or disposable vape pens)
Page Show If Used_12_months_medical_Solid
On the days that you used: Solid concentrate (e.g., shatter, budder, etc.) for medical purposes how much did you typically use in a day?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Solid concentrate (e.g., shatter, budder, etc.))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Solid concentrate (e.g., shatter, budder, etc.))
Page Show If Used_12_months_medical_Edibles
On the days that you used: Edibles (e.g., prepared food products) for medical purposes how much did you typically use in a day?
How many milligrams per serving of THC are in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Edibles (e.g., prepared food products))
How many milligrams per serving of CBD are in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Edibles (e.g., prepared food products))
Page Show If Used_12_months_medical_Liquid
On the days that you used: Liquid (e.g., cola/tea) for medical purposes how much did you typically use in a day?
(Please select the amount closest to what you typically use.)
How many milligrams per ml of THC are in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Liquid (e.g., cola/tea))
How many milligrams per ml of CBD are in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Liquid (e.g., cola/tea))
Page Show If Used_12_months_medical_Tinctures
On the days that you used: Tinctures (e.g., concentrated amounts ingested orally or taken under the tongue) for medical purposes how much did you typically use in a day?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Tinctures (e.g., concentrated amounts ingested orally or taken under the tongue))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Tinctures (e.g., concentrated amounts ingested orally or taken under the tongue))
Page Show If Used_12_months_medical_Topical
On the days that you used: Topical Ointments (e.g., lotions, salves, balms applied directly to the skin) for medical purposes how much did you typically use in a day?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Topical Ointments (e.g., lotions, salves, balms applied directly to the skin))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Topical Ointments (e.g., lotions, salves, balms applied directly to the skin))
Page Show If Used_12_months_medical_Fresh_Flower
On the days that you used: Fresh flower/leaf (e.g., for juicing) for medical purposes how much did you typically use in a day?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Fresh flower/leaf (e.g., for juicing))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Fresh flower/leaf (e.g., for juicing))
How much do you typically spend on cannabis for medical purposes each month?
Page Show If Is_Medical_User_30_Days
How much did you spend on cannabis for medical purposes in the past 30 days?
In the past 30 days, which of the following cannabis products did you use for medical purposes?
1 day per month |
2 or 3 days per month |
1 or 2 day(s) per week |
3 or 4 days per week |
5 to 6 days per week |
Daily | ||
---|---|---|---|---|---|---|---|
a. | Dried flower/leaf (smoked or vaporized) [Show If M19a_1_Dried_flower] |
2 | 3 | 4 | 5 | 6 | 7 |
b. | Hashish [Show If M19a_2_Hashish] |
2 | 3 | 4 | 5 | 6 | 7 |
c. | Cannabis Oil from a Health Canada Licensed Producer [Show If M19a_3_Cannabis_Oil_HC] |
2 | 3 | 4 | 5 | 6 | 7 |
d. | Liquid concentrate (e.g., hash oil, butane honey oil, etc.) [Show If M19a_4_Liquid_concentrate] |
2 | 3 | 4 | 5 | 6 | 7 |
e. | Cannabis oil cartridges or disposable vape pens [Show If M19a_5_Cartridges] |
2 | 3 | 4 | 5 | 6 | 7 |
f. | Solid concentrate (e.g., shatter, budder, etc.) [Show If M19a_6_Solid] |
2 | 3 | 4 | 5 | 6 | 7 |
g. | Edibles (e.g., prepared food products) [Show If M19a_7_Edibles] |
2 | 3 | 4 | 5 | 6 | 7 |
h. | Liquid (e.g., cola/tea) [Show If M19a_8_Liquid] |
2 | 3 | 4 | 5 | 6 | 7 |
i. | Tinctures (e.g., concentrated amounts ingested orally or taken under the tongue) [Show If M19a_9_Tinctures] |
2 | 3 | 4 | 5 | 6 | 7 |
j. | Topical Ointments (e.g., lotions, salves, balms applied directly to the skin) [Show If M19a_10_Topical_Ointment] |
2 | 3 | 4 | 5 | 6 | 7 |
k. | Fresh flower/leaf (e.g., for juicing) [Show If M19a_11_Fresh_flower] |
2 | 3 | 4 | 5 | 6 | 7 |
Page Show If Used_30_days_medical_Dried_Flower
Typically, how much cannabis in the form: Dried flower/leaf (smoked or vaporized) did you buy or receive each time for medical purposes?
(Please select the amount closest to what you typically use.)
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Dried flower/leaf (smoked or vaporized))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Dried flower/leaf (smoked or vaporized))
Page Show If Used_30_days_medical_Hashish
Typically, how much cannabis in the form: Hashish/kief did you buy or receive each time for medical purposes?
(Please select the amount closest to what you typically use.)
How much did you pay for this amount?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Hashish/kief)
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Hashish/kief)
Page Show If Used_30_days_medical_Cannabis_Oil_HC
Typically, how much cannabis in the form: Cannabis Oil from a Health Canada Licensed Producer did you buy or receive each time for medical purposes?
How much did you pay for this amount?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Cannabis Oil from a Health Canada Licensed Producer)
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Cannabis Oil from a Health Canada Licensed Producer)
Page Show If Used_30_days_medical_Liquid_Concentrate
Typically, how much cannabis in the form: Liquid concentrate (e.g., hash oil, butane honey oil, etc.) did you buy or receive each time for medical purposes?
(Please select the amount closest to what you typically use.)
How much did you pay for this amount?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Liquid concentrate (e.g., hash oil, butane honey oil, etc.))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Liquid concentrate (e.g., hash oil, butane honey oil, etc.))
Page Show If Used_30_days_medical_Cartridge
Typically, how much cannabis in the form: Cannabis oil cartridges or disposable vape pens did you buy or receive each time for medical purposes?
How much did you pay for this amount?
How many milligrams per cartridge/pen of THC are in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Cannabis oil cartridges or disposable vape pens)
How many milligrams per cartridge/pen of CBD are in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Cannabis oil cartridges or disposable vape pens)
Page Show If Used_30_days_medical_Solid
Typically, how much cannabis in the form: Solid concentrate (e.g., shatter, budder, etc.) did you buy or receive each time for medical purposes?
(Please select the amount closest to what you typically use.)
How much did you pay for this amount?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.)
(Solid concentrate (e.g., shatter, budder, etc.))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.)
(Solid concentrate (e.g., shatter, budder, etc.))
Page Show If Used_30_days_medical_Edibles
Typically, how much cannabis in the form: Edibles (e.g., prepared food products) did you buy or receive each time for medical purposes?
(Please select the amount closest to what you typically use.)
How much did you pay for this amount?
How many milligrams per serving of THC are in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Edibles (e.g., prepared food products))
How many milligrams per serving of CBD are in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Edibles (e.g., prepared food products))
Page Show If Used_30_days_medical_Liquid
Typically, how much cannabis in the form: Liquid (e.g., cola/tea) did you buy or receive each time for medical purposes?
(Please select the amount closest to what you typically use.)
How much did you pay for this amount?
How many milligrams per ml of THC are in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Liquid (e.g., cola/tea))
How many milligrams per ml of CBD are in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Liquid (e.g., cola/tea))
Page Show If Used_30_days_medical_Tinctures
Typically, how much cannabis in the form: Tinctures (e.g., concentrated amounts ingested orally or taken under the tongue) did you buy or receive each time for medical purposes?
How much did you pay for this amount?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Tinctures (e.g., concentrated amounts ingested orally or taken under the tongue))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Tinctures (e.g., concentrated amounts ingested orally or taken under the tongue))
Page Show If Used_30_days_medical_Topical
Typically, how much cannabis in the form: Topical Ointments (e.g., lotions, salves, balms applied directly to the skin) did you buy or receive each time for medical purposes?
How much did you pay for this amount?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Topical Ointments (e.g., lotions, salves, balms applied directly to the skin))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Topical Ointments (e.g., lotions, salves, balms applied directly to the skin))
Page Show If Used_30_days_medical_Fresh_Flower
Typically, how much cannabis in the form: Fresh flower/leaf (e.g., for juicing) did you buy or receive each time for medical purposes?
How much did you pay for this amount?
What percentage of THC is in this product? (tetrahydrocannabinol, is the substance in cannabis responsible for the “high” and other effects.) (Fresh flower/leaf (e.g., for juicing))
What percentage of CBD is in this product? (cannabidiol, is a substance in cannabis that does not produce the “high”, but has other effects.) (Fresh flower/leaf (e.g., for juicing))
MedicalDriving
You are almost done. We just have a few more questions about driving while using cannabis for medical purposes. We appreciate you taking the time to complete the remainder of this survey.
Section Show If Is_Medical_User
Page Show If Driven_within_2_hours_medical
In the past 12 months, how many times have you driven a motor vehicle (e.g. car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of using cannabis for medical purposes?
In the past 30 days, how many times have you driven a motor vehicle (e.g. car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of using cannabis for medical purposes?
Have you driven a motor vehicle (e.g. car, snowmobile, motor boat or all-terrain vehicle (ATV)) within 2 hours of using cannabis for medical purposes in combination with alcohol?
When did this last happen?
In the past 12 months, how many times have you been in a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) accident or collision with you as a driver after using cannabis for medical purposes within 2 hours before driving?
In the past 12 months, have you, as the driver, ever had an interaction with law enforcement involving driving under the influence of cannabis?
Have you ever been a passenger in a motor vehicle (e.g., car, snowmobile, motor boat or all-terrain vehicle (ATV)) driven by someone who had used cannabis for medical purposes within 2 hours before driving?
When did this last happen?
End
You have now completed the survey. Thank you very much for participating in this survey.
United States Department of Health and Human Services. Substance and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. National Survey on Drugs Use and Health, 2013. http://doi.org/10.3886/ICPSR35509.v3
Health Canada’s Canadian Tobacco, Alcohol and Drugs Survey: http://healthycanadians.gc.ca
Home Office, Office of National Statistics. Drug misuse. Finding from the 2013-2014 CSEW. http://www.gov.uk/government/statistics/tables-for-drug-misuse-findings-from-the-2013-to-2014-csew